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Key Points
• Dehydrated hereditary
stomatocytosis is
characterized by abnormal
RBC morphology but may
involve pseudohyperkalemia
and perinatal edema.
• This syndrome is associated
with germline mutations in
PIEZO1, encoding a
transmembrane protein that
induces mechanosensitive
currents.
Autosomal dominant dehydrated hereditary stomatocytosis (DHSt) usually presents
as a compensated hemolytic anemia with macrocytosis and abnormally shaped
red blood cells (RBCs). DHSt is part of a pleiotropic syndrome that may also exhibit
pseudohyperkalemia and perinatal edema. We identified PIEZO1 as the disease gene
for pleiotropic DHSt in a large kindred by exome sequencing analysis within the
previously mapped 16q23-q24 interval. In 26 affected individuals among 7 multigen-
erational DHSt families with the pleiotropic syndrome, 11 heterozygous PIEZO1
missense mutations cosegregated with disease. PIEZO1 is expressed in the plasma
membranes of RBCs and its messenger RNA, and protein levels increase during in
vitro erythroid differentiation of CD341 cells. PIEZO1 is also expressed in liver and
bone marrow during human and mouse development. We suggest for the first time
a correlation between a PIEZO1mutation and perinatal edema. DHSt patient red cells
with the R2456H mutation exhibit increased ion-channel activity. Functional studies
of PIEZO1 mutant R2488Q expressed in Xenopus oocytes demonstrated changes in
ion-channel activity consistent with the altered cation content of DHSt patient red
cells. Our findings provide direct evidence that R2456H and R2488Q mutations
in PIEZO1 alter mechanosensitive channel regulation, leading to increased cation transport in erythroid cells. (Blood. 2013;
121(19):3925-3935)
Introduction
Dehydrated hereditary stomatocytosis (DHSt), also known as he-
reditary xerocytosis (Online Mendelian Inheritance in Man [OMIM]
194380), is an autosomal dominant congenital hemolytic anemia
associated with a monovalent cation leak. DHSt consists of a usually
compensated hemolysis, associated with moderate splenomegaly.1,2
Blood smears show variable numbers of stomatocytes, sometimes
rare and ill-formed, and likely to be overlooked. The reticulocyte
count is elevated, and red cell mean corpuscular volume (MCV) is
slightly increased. DHSt red blood cells (RBCs) exhibit decreased
intraerythrocytic K1 content and increased intraerythrocytic Na1
content, usually accompanied by increased mean corpuscolar hemo-
globin (Hb) concentration. The cation leak of DHSt red cells
resembles that of control RBCs in its temperature dependence,
but is of greater magnitude at all temperatures.3 The deﬁnitive
diagnosis of DHSt is ascertained by osmotic gradient ektacytometry,
which shows a leftward shift of the bell-shaped curve.4,5 Occasion-
ally, associated hepatosiderosis beyond that expected from the mild
hemolytic state suggests a strong tendency to iron overload.6
Unlike hereditary spherocytosis, in which splenectomy can be
beneﬁcial, splenectomy in DHSt is contraindicated due to increased
risk of thromboembolic complications.7,8
DHSt can present as an isolated erythroid phenotype or as
associated with pseudohyperkalemia, with pre- and/or perinatal
edema, or with both pseudohyperkalemia and effusions. The pre- and/or
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perinatal edema is of chylous type and may lead to life-threatening
hydrops fetalis requiring therapeutic drainage.9-11 Remarkably, the
edema recede spontaneously before birth or within several
months postnatally, and do not reappear. In contrast, edema may
also be restricted to prenatal, clinically silent ascites detectable only
by ultrasound.12 Isolated familial pseudohyperkalemia (FP) is
deﬁned by the time-dependent elevation in serum [K1] when blood
samples are left for several hours or more prior to analysis at tem-
peratures below body temperature, whereas serum [K1] is normal
in freshly drawn blood. FP may be associated with DHSt or, when
linked to chromosome 2, as isolated FP. The causative gene of
isolated FP linked to 2q35-36 was recently identiﬁed as ABCB6,
encoding a porphyrin transporter.13
Mapping of gene(s) responsible for familial DHSt identiﬁed
a cosegregating critical region at the telomeric region of 16q.14-17
Zarychanski and colleagues reported for the ﬁrst time, in 2 families
with isolated DHSt, 2 missense mutations in the FAM38A gene
encoding PIEZO1.18 We report here our independent ﬁndings in 7
unrelated families with isolated DHSt, DHSt with pseudohyperkal-
emia, or DHSt with both pseudohyperkalemia and pre-/perinatal
ﬂuid effusion, novel mutations in the PIEZO1 gene that cosegregate
with the multiple disease phenotypes. We have further characterized
PIEZO1 expression in erythroid cells and during mouse and human
development, and performed functional studies on R2488Q and
R2456H mutations in human erythrocytes and Xenopus oocytes.
Material and methods
Case report
The clinical phenotypes of kindreds Arras (AR), Biceˆtre (BI), Dax (DA), Essex,
and Troyes (TR) were previously described.14,15 Deﬁnitive diagnosis of DHSt
was made by ektacytometry. Families Dax and Troyes showed isolated DHSt.
Families Arras and Edinburgh showed DHSt plus pseudohyperkalemia.15,19,20
Family Biceˆtre exhibited DHSt accompanied by pseudohyperkalemia and
massive perinatal ﬂuid effusions that spontaneously and permanently regressed
within several months after birth.10,15 Similar massive but transient perinatal
ﬂuid effusions have been observed by others.9,11,21,22 Following our initial
studies, the patients were followed up locally.
The expressivity of the phenotype was generally similar among members
from a given kindred, but some variability was noted. (1) In family Dax,
the MCV and ektacytometric curve of the father (II.1; numbering from
Grootenboer et al) were only slightly altered, whereas the son (II.2) exhibited
a full-ﬂedgedDHSt.15 (2) In family Biceˆtre, whereasDHSt in father II.3,23 was
accompanied by pseudohyperkalemia and dramatic perinatal fuid effusions,
his 2 children exhibited effusions which were less pronounced. Splenectomy
was performed in only 2 patients. In keeping with Stewart et al,7 member II.2
of family AR15 developed a thrombosis after a period in an ankle cast,
followed some years later by a moderately severe pulmonary embolus, treated
by chronic anticoagulation. The second patient, member II.2 of family DA,15
was without thromboembolic complication at the time of examination.
Patient SF, a 38-year-old female triathlete, has not been reported pre-
viously. She was referred by her primary physician to a hematology clinic for
evaluation of hemolytic anemia, ﬁrst diagnosed at age 14 in the setting of
severe weakness of 1-month duration. Similar episodes of weakness recurred
once in her 20s and again at the age of 32, unrelated to medications or speciﬁc
foods, and resolving with supportive care. The patient reported chronic
“yellowing of her eyes,”without changes in color of urine or stool, andwithout
fevers or gastrointestinal symptoms. Neither medication nor food triggered
these episodes. Family history was notable for recently diagnosed hemolytic
anemia in the patient’s brother, accompanied by 50% deﬁciency of pyruvate
kinase, and a report of mild anemia of unclear etiology in the patient’s father.
Physical examination revealed mild scleral icterus and hepatomegaly (edge
1 cm below costal margin). Hematologic indices were: Hb, 13.2 g/L;
hematocrit, 37%; RBCs, 3.573 106mm3;MCV, 103.7 fL; red cell distribution
width, 13.1%; absolute reticulocyte count, 139,300/mL. The peripheral blood
smear revealed spherocytes, macrocytes, and rare stomatocytes and tear drops
(supplemental Figure 1A-B, available on the Blood website; see the
supplemental Materials link at the top of the online article). Total bilirubin
was 1.4 mg/dL, with normal lactate dehydrogenase, and testing for Gilbert
syndrome was negative. Direct Coombs test was negative, and red cell
glutathione and enzyme activities (G6PD, PK, GPI, HK, ADA) were normal.
Osmotic fragility testing (supplemental Figure 1C) and ektacytometry
(supplemental Figure 1D) revealed osmotic resistance, and ektacytometry
also showed decreased RBC deformability in hypertonic solutions: hypo-
osmotic point was 112.8 (normal, 139.8 1 16.0 mOsm/kg); maximum
deformability index was 0.63 (normal, 0.54 1 0.06 artiﬁcial units), osmotic
point was 348.7 (normal, 405.61 18.3 mosmol/kg). These results supported
the clinical diagnosis of dehydrated stomatocytosis (DHSt) in patient SF.
Bioinformatic analysis for exome sequencing
Reads were aligned to the most recent version of human genome (GRCh37/
hg19) using the BWA software package (version 0.5.9). Mapped reads were
consequently ﬁltered out for polymerase chain reaction (PCR) duplicates by
Samtools (version 0.1.18)24 locally realigned around inferred insertions and
deletions, and their base qualities recalibrated in the context of alignment by
Genome Analysis Toolkit (version 1.4-21).25
Single-nucleotide polymorphisms, short insertions, and deletions were
identiﬁed by the GATK Uniﬁed Genotyper. Resulting variants were ﬁltered
out for possible sequencing and alignment artifacts, taking into consideration
variant quality, variant read-depth, and the proportion of not-uniquely-mapped
reads overlapping variants (supplemental Table 1). Prediction tracks for each
mutation were generated by automatic queries to Mutation Taster26 and
PolyPhen-2.27 Output data were ﬁltered on the basis of an autosomal dominant
model of inheritance, removing those annotated variants which were out-of-
exome target, synonymous, common (as annotated in dbSNP135), or found in
previous exome sequencing of uncorrelated samples. Candidate variants were
also compared and prioritized with the 1000 Genome Project Database and the
Exome Sequencing Project (ESP) Database (Exome Variant Server, HLBI
ESP, Seattle, WA; ESP5400 release). The remaining, ﬁltered variants were
assessed for pathogenicity by SIFT.28 The ﬁltered exome sequencing data
were graphically visualized with Integrative Genomics Viewer, allowing
interactive exploration of these genomic datasets.29
RNA isolation and cDNA synthesis from CD341 cells
Total RNA was isolated30 from CD341 cells at days 0, 7, and 14 of erythroid
differentiation. Single-strand complementary DNA (cDNA) was synthesized
from 2 mg of RNA template, using 2.5 units of VILO reverse transcriptase
(Life Technologies, Milan, Italy).
Two microelectrode voltage clamp of PIEZO1-expressing
oocytes
Oocytes were harvested from Xenopus laevis and treated with collagenase as
previously described.31-34 cRNA was injected in a volume of 50 nL, and
oocytes were maintained at 17°C for 72 hours prior to experimentation.
Defolliculated oocytes were placed in ND96 (in mM, 96 NaCl, 2 KCl, 1.8
CaCl2, 1 MgCl2, 5 HEPES [N-2-hydroxyethylpiperazine-N9-2-ethanesulfonic
acid], pH 7.4) in a bath (RC-16; Warner Instruments, Hamden, CT) on the
headstage of an upright microscope and imaged at 320 magniﬁcation.
Oocytes were impaled with pipettes fabricated from borosilicate glass (World
Precision Instruments, Sarasota, FL) using a Sutter P87 puller. Resistances of
electrodes were 2 to 10 megaohms when ﬁlled with 3M KCl.
A voltage clamp protocol was generated using the Clampex subroutine of
PCLAMP 10 (Molecular Devices Corporation, Sunnyvale, CA), applying 10
sweeps of 400 ms, in 20-mV steps from 270 mV, with a sampling rate of 10
kHz. Holding potential was230 mV in all groups throughout the experiment.
Currents were recorded using a Geneclamp 500 voltage clamp (Molecular
Devices). The bath reference electrode was a silver chlorided wire with a 3M
KCl agar bridge. Junction potentials were minimized by using 3M KCl in the
pipettes and by use of a bath clamp.
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Current voltage relationships were determined by ﬁtting the currents
recorded at t 5 370 ms using the Clampﬁt subroutine of PCLAMP 10, and
plotted with Sigmaplot graphics.
On-cell patch recording of PIEZO1-expressing oocytes
Defolliculated oocytes were placed in a hypertonic bath and the vitelline
layer was removed by hand with Dumont no. 5 forceps under 340 mag-
niﬁcation. The devitellinized oocyte was immediately placed in a low-
volume bath (RC-25; Warner Instruments) on the stage of an Olympus
IMT-2 inverted microscope, imaged at 340 and patched with ﬁre-polished
pipettes of 7 to 12 megaohms resistance. Bath and pipette solutions contained
(in mM) 150 Na methanesulfonate, 10 Na EDTA, and 10 Na HEPES, pH 7.4.
On-cell patch recording was performed as previously described in this
paragraph, except that currents were elicited by imposition of a 250-ms
linear voltage ramp from 2100 mV to 1100 mV during application of
negative pressure (0 or 225 mm Hg) to the pipette port and recorded by
pneumatic transducer (Biotek DPM-1B, Winooski, VT).
Results
Whole-exome analysis
Whole-exome analysis was performed on 2 affected and 2 unaffected
members from family Edinburgh (DHSt plus pseudohyperkalemia).
After ﬁltering out of likely false-positive single-nucleotide variations
(SNVs) and short insertions/deletions (InDels), an average of 32 362
variants was called for each of the 4 exomes, spanning about 12 053
genes, with about 1700 novel SNVs/InDels per sample. Among
novel SNVs/InDels, we focused on heterozygous variants falling
in exons, splice-site junctions and 59 and 39 untranslated regions
that segregated with disease among the 4 individuals and were
absent from 38 unrelated exomes from our internal database. This
approach highlighted 13 variants in as many genes, 7 of which were
exonic, 5 of which were predicted as likely pathological by the in
silico tools Mutation Taster, PolyPhen-2, and SIFT (supplemental
Table1). One of these variants mapped within the previously
deﬁned critical region on chromosome 16,20 and was identiﬁed as
c.6380C.T, T2127M of PIEZO1 (Table 1).
PIEZO1 mutational analysis
We sequenced PIEZO1 in 26 affected and 16 healthy subjects among
7 affected families. The pedigrees from previous studies14,15,20 are
illustrated in supplemental Figure 2. The mutations and the number
of affected and unaffected subjects are described in Table 1.
The nucleotide changes are shown in Figure 1A. None of the noted
nucleotide changes were present in the 1000 genomes database, or in
50 healthy subjects here analyzed. The amino acids affected by the
PIEZO1 missense mutations identiﬁed in the DHSt patients are
located in 2 regions of the 2521 amino acid PIEZO1 polypeptide: 1
between residues 718 and 1117, and the carboxy-terminal region
beyond residue 2000 (Figure 1B). The DHSt phenotype in families
AR, Essex, and BI cosegregated with.1 novel missense mutation in
cis in PIEZO1 (Table 1). The mutated amino acid residues are all
conserved in PIEZO1 of macaque and mouse; 9 of the 10 residues are
conserved in rat PIEZO1, and 7 of the 10 are conserved in Xenopus
tropicalis and Danio rerio (Figure 1C).
PIEZO1 expression in human and mouse during fetal and
embryonic development
We analyzed PIEZO1 expression in several mouse and human tissues
during embryonic development to account for the erythroid in-
volvement of DHSt and for the ﬂuid effusions occurring in some
DHSt families. We collected mouse embryos at embryonic day (E)
9.5, E10.5, E12.5, E15.5 and postnatal day 0 (P0; at birth) for
quantitative PCR analysis of murine PIEZO1 expression. PIEZO1
messenger RNA (mRNA) abundance increased gradually from E9.5
to E15.5 and was sustained through birth (Figure 2A-B).
We further showed PIEZO1 polypeptide expression in adult
RBC membranes from mice (Figure 2C) and humans (Figure 2D).
PIEZO1 immunohistochemical analyses were performed on
human fetal tissues (17 weeks of gestation) to verify PIEZO1 ex-
pression in liver, spleen, and peritoneum lymphatic vessels. In fetal
liver, PIEZO1 showed strong cytoplasmic and membrane signals
particularly in hepatic erythroblasts. Fetal spleen at 17 weeks showed
positive cytoplasmic staining patterns in splenic plasma cells.We also
analyzed PIEZO1 expression in lymphatic vessel of fetal peritoneum
at gestational week 17 to examine the correlation between PIEZO1
expression and occurrence of perinatal edema. PIEZO1 showed
amarked signal in lymphatic vessels (Figure 2E). In contrast, PIEZO1
immunoreactivity was absent from peritoneal lymphatic vessels of
healthy human adult subjects. This observation provides a ﬁrst link
between PIEZO1 mutations and pre- or perinatal edema.
PIEZO1 expression and localization in RBCs
PIEZO1 localization in RBCs was evaluated in healthy controls.
Confocal microscopy analysis showed that PIEZO1was expressed on
the RBC membrane, as demonstrated by its complete colocalization
with the erythroid membrane marker glycophorin A (Figure 3A), and
Table 1. PIEZO1 mutations found in the families here analyzed
Family (code) DHSt FP PO Nucleotide mutations Amino acid mutations*
Genotype
ReferenceAllele 1* Allele 2
Arras (AR) 1 1 c.7463 G.A p.R2488Q p.R2488Q WT 15
c.2152 G.A p.G718S p.G718S WT
Edinburgh 1 1 c.6380 C.T p.T2127M p.T2127M WT 20
Essex 1 c.3350 C.T p.S1117L p.S1117L WT 14
c.6059 C.T p.A2020V p.A2020V WT
Dax (DA) 1 c.6495-6508delAGA p.2166-2169 delK p.2166-2169 delK WT 15
Bicetre (BI) 1 1 1 c.1848131C.G WT 15
c. 2344 G.A p.G782S p.G782S WT
c. 2423 G.A p.R808Q p.R808Q WT
Troyes (TR) 1 c.6008 C.A p.A2003D p.A2003D WT 15
San Francisco (SF) c.7367 G.A p.R2456H p.R2456H WT Unpublished
PO, perinatal edema; 1, presence of the clinical characteristics.
*Novel mutations are highlighted in bold.
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Figure 1. Mutational analysis. (A) Schematic representation of PIEZO1 (blue squares, exons; horizontal double lines, introns; double slashes, large introns); red arrows
indicate exonic positions of the nucleotides mutated in the 7 families in whom DHSt was previously mapped to chromosome 16q. (B) A 2-dimensional (2D) hydropathy profile
of human PIEZO1 protein. The transmembrane regions of PIEZO1 (UniProt accession Q92508) predicted by TMHMM were displayed using TMRPres2D. Red circles mark
approximate locations of DHSt-associated missense mutations. (C) Evolutionary conservation of the residues mutated in our DHSt patients (red-shaded boxes) among the
species indicated at left.
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Figure 2. PIEZO1 characterization during mouse and human embryonic development. (A) PIEZO1 mRNA levels (normalized to GAPDH) in murine C57BL/6
embryos at E9.5, E10.5, E12.5, E15.5 and P0. Mean 1 SEM of 3 experiments. (B) Immunoblot showing expression of PIEZO1 protein expression in lung, spleen,
liver, and bone marrow from P0 C57BL/6 mouse. Protein (50 mg) was loaded in each lane, with GAPDH as loading control. Representative of 2 independent fresh
tissue lysate preparations. (C) Immunoblot showing PIEZO1 protein RBC membranes prepared from blood pooled from 8 adult C57BL/6 mice. Protein (50 or 100 mg)
was loaded in each lane, with GAPDH as loading control. One of 3 similar experiments with independent membrane preparations. (D) Immunoblot showing PIEZO1
protein in human RBC membranes prepared from blood pooled from 3 healthy subjects for each lane. Protein (50 mg) was loaded in each lane, with GAPDH as
loading control. One of 3 similar experiments with independent membrane preparations. (E) Immunohistochemical expression in human fetal (17 weeks of
gestations) and adult tissues with PIEZO1 rabbit polyclonal antibody. The red arrow in the 3400 liver panel indicates a positive erythroblast. The red arrows in the
fetal peritoneum panels indicate positive staining in the lymphatic vessels, while in the adult peritoneum panels indicate negative staining in the lymphatic vessels.
Antigen is stained brown; nuclei are stained in purple with hematoxylin. Tissues were imaged with a Leica microscope equipped with 203 and 633 objectives.
Representative of 3 independent experiments. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
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conﬁrmed by colocalization with the membrane marker CD55/DAF
(supplemental Figure 3; negative control immunoﬂuorescence ex-
periments are shown in supplemental Figure 4).
The data conﬁrm previous mass spectrometry data of Zarychan-
ski et al18 showing the presence of PIEZO1 protein in red cell
membranes.
Figure 3. PIEZO1 characterization in
RBCs and in CD341 blood cells during
erythroid differentiation. (A) Laser-
scanning confocal immunofluorescence
images of a peripheral blood smear
from a control subject stained with rabbit
polyclonal antibody to PIEZO1 (red) and
mouse monoclonal antibody to glyco-
phorin A (membrane marker, green),
showing colocalization of the 2 sig-
nals (merge), and a bright-field image
of a red cell. Cells were imaged with a
Leica TCS SMD FLIM confocal micro-
scope equipped with a 1.4 NA oil-
immersion HCX PL APO CS 1003
objective. Luminosity and contrast were
uniformly adjusted with Axiovision soft-
ware. Representative of 3 independent
experiments. (B) PIEZO1 mRNA levels
(normalized to GADPH) in CD341 cells
induced to erythroid differentiation by
EPO at 0, 7, and 14 days by quantitative
reverse transcription PCR. *P value,
.003 (CD341 14D vs CD341 7D). (C) Im-
munoblot of PIEZO1 protein in lysate
of CD341 cells induced to erythroid dif-
ferentiation at 0, 7, and 14 days (50 mg of
protein; GAPDH was loading control).
The graph below shows densitomteric
analysis of this and similar blots. (D)
Laser-scanning confocal microscopy
images of CD341 cells induced to differ-
entiation at 7 and 14 days by EPO,
showing colocalization of PIEZO1 (red)
and glycophorin A (green). Cells were
imaged with a Leica TCS SMD FLIM
confocal microscope equipped with a
1.4 NA oil-immersion HCX PL APO CS
633 objective. Bright-field images show
the morphology of CD341 cells after 7
or 14 days of erythroid differentiation.
Luminosity and contrast were adjusted
using Axiovision software. (E) PIEZO1
mRNA levels (normalized to GAPDH) in
HEK-293 cells transiently transfected
(72 hours) with empty vector or with cDNA
encoding WT PIEZO1 or PIEZO1 mu-
tants R2488Q and R2456H. Mean 1
SEM of 3 experiments. (F) Immunoblot
of PIEZO1 polypeptide in HEK-293 cells
transiently transfected (72 hours) with
empty vector or with cDNA encodingWT
PIEZO1 or PIEZO1 mutants R2488Q
and R2456H. GAPDH serves as loading
control. One of 2 similar experiments.
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PIEZO1 expression during erythroid differentiation
To investigate the role of PIEZO1 in erythroid cells, we ﬁrst ex-
amined PIEZO1 expression and localization in an ex vivo model
of erythroid differentiation. CD341 cells isolated from the peripheral
blood of healthy volunteers were induced to erythroid differentiation
by 14 days of erythropoietin treatment, as detailed in “Materials
and methods.” As shown in Figure 3B, PIEZO1 mRNA was sig-
niﬁcantly upregulated after 14 days of erythropoietin treatment
(P 5 .003). These data were conﬁrmed at the protein level by
western blotting and densitometric analysis (Figure 3C).
We then assessed PIEZO1 protein localization in the same cell
systems. As shown in Figure 3D, PIEZO1 colocalized with the
plasma membrane marker glycophorin A at 7 and 14 days of CD341
erythroid differentiation (Figure 3D). No PIEZO1 immunoreactivity
was detected in day 0 CD341 cells (not shown).
Expression of WT and mutant PIEZO1 polypeptides in
HEK-293 cells
To evaluate expression of the PIEZO1 mutants, we cloned PIEZO1
wild-type (WT) and PIEZO1 mutants R2488Q and R2456H in
pCMV6-IRES-GFP and transiently transfected the recombinant
plasmids into HEK-293 cells. We found that neither mutation impaired
PIEZO1 expression at mRNA or protein levels (Figure 3E-F).
DHSt red cells exhibit altered ion content and transport
Patient SF red cells heterozygous for the PIEZO1 mutation R2456H
had elevated Na content of 61 mmol/kg Hb and reduced K content of
219 mmol/kg Hb (after overnight shipment). Magnesium (Mg) content
was slightly elevated at 9.7 mmol/kg Hb. Red cell activities of K-Cl
cotransport, Na-K-2Cl cotransport, andNa/H exchangewere not higher
than in unrelated control cells (not shown). On-cell patches recorded
from patient SFDHSt red cells as described in “Materials andmethods”
(Figure 4A) revealed spontaneous ion-channel activity (lower trace) not
detected in cells from an unrelated subject (upper trace). This activity
was characterized by a distribution of channel open probability (NPo) of
1.47 1 0.43 (Figure 4B), a single-channel ohmic conductance of 13
single channel conductance (pS) with reversal potential 211 mV
(r2 5 0.95; Figure 4C), and was competely blocked by 2.5 mM
Grammastola spatulata mechanotoxin-4 (GsMTx4) in the pipet
(P , .05).
Function of WT and mutant PIEZO1 expressed in
Xenopus oocytes
X laevis oocytes previously injected with hPIEZO1 complementary
RNA (cRNA) were subjected after 72 hours to 2-electrode voltage
clamp recording. Uninjected oocytes exhibited a small linear current
at holding potentials between 2100 and 180 mV, with reversal
potential of 264 mV (Figure 5A). After 14 minutes of exposure to
a moderately hypotonic bath (20% dilution of ND-96 which, based
on the low intrinsic oocyte water permeability35 should produce only
minimal swelling), these properties remained essentially unchanged.
Oocytes previously injected with PIEZO1 cRNA exhibited slightly
elevated currents in ND-96, but with a reversal potential depolarized
to 240 mV. However, and in contrast to uninjected oocytes, 14-
minute exposure of PIEZO1-expressing oocytes to hypotonic bath
conditions substantially increased an outwardly rectifying current,
while hyperpolarizing reversal potential to 256 mV (Figure 5A).
Exposure of oocytes previously injected with PIEZO1 cRNA to
hypertonic bath (ND-96 containing 200 mM mannitol, 15 minutes)
also led to increased current (not shown).
Because mPIEZO1 exhibits mechanosensitivity, multichannel
on-cell patch currents of Xenopus oocytes expressing hPIEZO1 were
recorded during voltage ramps before and during application of
225 mm Hg suction via pipet. As shown in Figure 5B, negative
pressure did not alter current in uninjected oocytes. In contrast,
negative pressure induced increased currents in oocytes expressing
PIEZO1 (P, .005) and mutant R2488Q (P, .001), but not mutant
R2456H (Figure 5C). The response of mutant R2488Q to negative
pressure appeared to exceed that of WT PIEZO1 (P 5 .057).
Occasional oocyte patches allowed resolution of single-channel
activity, as illustrated in Figure 6 and in supplemental Figure 5. In these
resting state patches, the uninjected oocyte NPo of 0.013 increased to
0.69 in oocytes expressing WT PIEZO1, 0.88 in oocytes expressing
PIEZO1 mutant R22488, and 0.22 in oocytes expressing mutant
R2456H. Respective single-channel conductances were 25 pS
(WT), 26.5 pS (R2488Q), and 43 pS (R24566H).
Figure 4. Cation channel activity in on-cell patch
recordings of DHSt red cells from patient SF. (A)
Representative graphs of channel activity in on-cell
patches from an unrelated normal cell (above) and
a DHSt red cell from patient SF. (B) NPo of channel
activity in DHSt red cells from patient SF (n 5 4), from
an unrelated volunteer (Control, n5 3) and from patient
SF in the presence of pipet GsMTx-4 (2.5 mM; n 5 3);
*P, .05. (C) I-V curve of a representative on-cell patch
record from a DHSt red cell of patient SF.
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Discussion
We have identiﬁed PIEZO1 as the causative gene for the varied
clinical forms of autosomal dominant DHSt linked to chromosome
16p. PIEZO1 was selected as a strong candidate gene within the
critical region previously mapped to 16q23-qter based on exome
sequencing analysis in family Edinburgh. Subsequent targeted
sequencing analysis identiﬁed several additional novel PIEZO1
mutations in 7 families with DHSt syndromes. PIEZO1 protein
Figure 5. PIEZO1 expressed in Xenopus oocytes confers in-
creased current elicited by hypotonic medium and negative
pressure activates currents in on-cell membrane patches of WT
PIEZO1 and mutant R2488Q. (A) Current-voltage relationship of
2-electrode voltage clamp records from uninjected oocytes or
oocytes previously injected with cRNA encoding PIEZO1, before
and 14 minutes after bath change to a slightly hypotonic solution
(ND-96 diluted 20% with distilled water). (B) On-cell patches were
established on surface membranes of uninjected Xenopus oocytes or
oocytes previously injected with cRNA encoding WT PIEZO1 or
mutants R2488Q or R2456H. Currents were recorded during 250-msec
voltage ramps between 2100 mV and 1100 mV. Representative traces
from an uninjected oocyte and an oocyte expressingWT PIEZO1 during
pipet application of 225 mm Hg hydrostatic pressure. (C) Bar graph of
the magnitidue of the current differences between values recorded at 2
100 and 1100 mV in on-cell patches from (n) uninjected oocytes or
oocytes previously injected with cRNAs encoding WT PIEZO1 or
the indicated mutants, in voltage ramp experiments such as shown in
panel A. At 225 mm hydrostatic pressure, uninjected oocytes differed
from oocytes expressing WT PIEZO1 or mutant R2488Q, but not
from mutant R2456H (P , .05, Kruskal-Wallis ANOVA with the Dunn
post-test).
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expression was characterized during human and murine de-
velopment and during erythroid differentiation. Functional studies
demonstrated for the ﬁrst time that PIEZO1 mutations cause
altered ion transport in erythroid cells. PIEZO1 protein was also
detected in fetal lymphatic vessel endothelium, consistent with its
proposed causative role in the pathogenesis of perinatal effusions.
Electrophysiology analysis in oocytes demonstrated changes in
ion transport consistent with the altered ion content of DHSt
patient red cells. A ﬂowchart illustrating our study design is shown
in supplemental Figure 6.
The PIEZO1 open reading frame was ﬁrst found in the human
immature myeloid cell line KG-1, and transcript tissue proﬁles
showed apparently ubiquitous expression.36 Satoh et al demon-
strated transcriptional induction of PIEZO1 in senile plaque-
associated astrocytes from Alzheimer disease patients.37 PIEZO1
involvement in integrin activation requires recruitment to the
endoplasmic reticulum of the small GTPase R-Ras, promoting
release of Ca21 from intracellular stores to activate cytoplasmic
calpain.38 Recently, PIEZO1 and PIEZO2 were both implicated
in mechanosensation as stretch-activated cation channels.39-42
Soon thereafter, expression in human cells of the single
Drosophila melanogaster PIEZO (DmPIEZO or CG8486) was
shown to resemble its mammalian counterparts in its ability to
induce mechanically activated currents.43 Behavioral responses
to noxiousmechanical stimuli were severely reduced in DmPIEZO
knockout larvae, whereas responses to light touch or to other
types of noxious stimulus were unaffected. Human PIEZO1 is
an N-linked glycoprotein44 that serves as substrate for both
acetylation45 and phosphorylation.46,47 Coste et al further showed
that mouse PIEZO (MmPIEZO1) can assemble as a 1.2-mega-
dalton homo-oligomer with a total of 120 to 160 transmembrane
segments, the largest homomeric plasma membrane ion-
channel complex identiﬁed to date.39 Puriﬁed MmPIEZO1
reconstituted into asymmetric lipid bilayers and liposomes forms
ruthenium-red–sensitive ion channels in the absence of any other
protein.39
Figure 6. On-cell patch current traces of R2488Q and R2456H mutations in Xenopus oocytes. On-cell patch current traces (recorded at 2applied voltage at the
membrane patch (VP) 5 2100 mV) and current-voltage relationships from (A) uninjected oocytes and (B) oocytes previously injected with cRNA encoding WT PIEZO1, (C)
PIEZO1 mutant R2488Q, and (D) PIEZO1 mutant R2456H. Single-channel slope conductances are 25 pS (wildtype), 26.5 pS (R2488Q), and 43 pS (R2456H). Supplemental
Figure 3S presents a higher resolution on-cell patch trace from an oocyte expressing mutant R2456H.
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We here characterized PIEZO1 expression during mouse and
human development. We have shown that PIEZO1 expression
increased during murine embryogenesis and, at birth, expression
was predominant in liver and bone marrow. In fetal human
tissues, PIEZO1 showed marked expression in liver and spleen.
Of note, PIEZO1 was expressed in lymphatic vessels of the fetal
peritoneum and was absent in adult lymphatic vessels, demon-
strating for the ﬁrst time a potential physiological link between
PIEZO1 mutations and the perinatal edema that sometimes
accompanies DHSt.
We also identiﬁed PIEZO1 expression and localization in the
plasma membrane of RBCs, conﬁrming immunologically the
original mass spectroscopic identiﬁcation of PIEZO1 as part of
the red cell membrane proteome,48 and its subsequent detection
in red cell membrane by targeted mass spectrometry.18
In 3 unrelated families, we found multiple in cis missense muta-
tions in PIEZO1. R2488Q mutation in family Arras altered a residue
conserved in all analyzed species (Figure 1C), and the linked mutation
G718S altered a residue conserved in all tested species exceptD rerio.
A2020V mutation in family Essex altered a completely conserved
residue, and linked mutation S1117L altered a residue conserved in all
tested species except X tropicalis and D rerio. The linked variants at
sites of lesser evolutionary conservation are not, however, present
among normal alleles and SNV databases, and so may not be harmless
variants. Further studies will elucidate the origin of geographic
clustering of these mutations. However, the contribution of each
individual mutation to its linked clinical phenotype cannot yet be
assigned. At this time, we do not know which one of the mutations
coinherited in cis might be individually responsible for the disease
phenotype, or whether disease arises from the combined effects
of the coinherited mutations. Interestingly, the 2 families car-
rying 2 novel, linked mutations exhibited the phenotype of DHSt
plus pseudohyperkalemia, but affected individuals in the single
family characterized by 3 allelic mutations exhibited a more
complex phenotype of DHSt plus perinatal edema and pseudohy-
perkalemia. The connections linking genotype to the red cell
dehydration phenotype and to phenotypic variability could reﬂect
mutation position within the 3-dimensional structure of the
PIEZO1 polypeptide (allelic heterogeneity) and/or modiﬁer gene
coinheritance.
Patient SF exhibited the same mutation, R2456H, found in one
of the families reported by Zarychanski et al.18 Our patient and
the previously reported R2456H patients showed a similar
phenotype characterized by DHSt unaccompanied by pseudohy-
perkalemia or perinatal edema. In contrast to the report of
Zarychanski and colleagues, our families exhibited only hetero-
zygous mutations, as predicted for a simple pattern of dominant
inheritance.
The presence of PIEZO1 in the red cell membrane suggests
a link to the erythroid ion imbalance and altered erythroid ion-
channel activity of DHSt patients. Functional studies in Xenopus
oocytes demonstrated that WT PIEZO1 expression increased 2-
electrode voltage clamp current elicited by osmotic swelling, and
channel activity in cell-attached patches. The PIEZO1 mutation
R2488Q increased hydrostatic pressure-induced currents in
on-cell patches of Xenopus oocytes, likely reﬂecting, in part,
increased NPo. Oocytes expressing PIEZO1 mutant R2456H
exhibited cell-attached patch currents of elevated single-channel
conductance. These properties of oocytes expressing PIEZO1
mutants are consistent with the steady-state elevation of in-
tracellular Na1 and reduction of intracellular K1 that character-
ize red cells of DHSt patients. However, the link between
PIEZO1 mutations and the combination of elevated MCV and
mean corpuscolar Hb concentration which underlie the descriptor
“dehydrated stomatocytosis” will require further experimenta-
tion. Further experiments will be needed to conﬁrm individual
mutation-selective changes in single-channel characteristics
suggested by the present data. Detailed comparison of functional
effects of endogenous WT and mutant PIEZO1 in intact red cells
with those of heterologous WT and mutant PIEZO1 expressed in
Xenopus oocytes will also require additional experiments. These
will be directed toward a greater understanding of differences
between the chronic effects and inﬂuences of WT and mutant
PIEZO1 channels on cell volume and ion content and the rapid
kinetics of PIEZO1 channels recorded in whole-cell and patch
modes. Such differences are inﬂuenced by the still incompletely
deﬁned changes in membrane tension and cytoskeletal dynamices
inside the patch pipet containing the distinct plasma membranes of
fetal erythrocytes, adult erythrocytes, and Xenopus oocytes. All of
these, in turn, likely differ from the strains experienced by the
membranes of intact red cells over their normal 120-day lifespan as
they experience a range of laminar and turbulent shear stresses
during their circulation through vessels ranging in diameter from
the ventricular chamber and the aorta to capillary tortuosities,
and accompanied by sequential adhesions to and releases from
other blood cells and endothelial cells.
In conclusion, DHSt is a pleiotropic syndrome caused by
dominant PIEZO1 mutations. In particular, R2456H and R2488Q
mutations in PIEZO1 likely alter mechanosensitive channel
regulation, leading to increased cation transport in erythroid
cells. Ongoing functional analysis should further elucidate the
pathogenic mechanisms of all PIEZO1 mutations found in simple
and syndromic forms of DHSt.
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